Verovaccines gets larger research facility as company goes standalone
German start-up Verovaccines will further develop its pipeline at a new R&D facility in Halle.
Exchange rates, US de-stocking mask Virbac's healthier underlying Q2 performance
Virbac sales declined by 0.7% in the second quarter of the year – a performance obscured by currency exchange rates.
Animal Pharm podcast #12: Could an IPO be the most viable option for Elanco?
With a decision on Elanco's future due in a week, Animal Pharm editor Joseph Harvey provides a recap of the company's situation and what can be expected over the next seven days.
DSM to stimulate above-market animal nutrition growth with gut health, digitization
Royal DSM aims to continue outperforming the global animal nutrition market through gut health innovation, geographic expansion and M&A in the premix area.
Latest Articles
Analysis of Elanco's future
Rumor mill spins faster three months before Elanco's future is revealed
With Elanco's date with destiny set for July 24 (the day of Eli Lilly's second-quarter results), the rumors of potential acquirers have ramped up.
Recent Tweets from Animal Pharm
Tweets by animalpharm
Commercial
Zoetis intensifies monoclonal antibody focus with Regeneron link-up
Zoetis has further built on its burgeoning monoclonal antibody portfolio by partnering with US firm Regeneron Pharmaceuticals.
Latest From Commercial
US veterinary compounding companies to merge following acquisition
US veterinary drug compounding firms Wedgewood Pharmacy and Diamondback Drugs have agreed to a merger.
Boehringer extends Nexgard indications with new approval
Boehringer Ingelheim Animal Health's NexGard antiparasitic chewable tablet for dogs has gained a supplemental approval from the US FDA for the prevention of a bacterial infection.
Nutrition, vaccines and tech start-ups under spotlight at aqua forum
The upcoming Aquaculture Innovation Summit hosted by Kisaco Research will shed light on innovations such as bacteriophages and oral vaccines.
Macdonald moves from Virbac to Zoetis in New Zealand
Vanessa Macdonald has become the general manager of Zoetis' business branch in New Zealand.
Anatara defends Zoetis deal as shares sink
Australian firm Anatara Lifesciences has addressed its recent share price slump, which it has linked to a development deal with Zoetis.
Orion delivery issues impact sales in Q2
Orion Animal Health has seen 14.5% drop in sales during the second quarter of 2018.
Top Interviews & Analysis
Animal health industry rankings 2017: One big Boehringer-sized change masks ongoing vibrancy across big players
This year's rankings are dominated by the changes brought by Boehringer Ingelheim's acquisition of Merial. However, the fiscal 2017 standings highlight many more trends and movements. Animal Pharm editor Joseph Harvey looks at a largely positive year for the top lines of animal health's leading players.
TwistDx offers RPA as versatile alternative for veterinary diagnostics
It might only be a matter of time before pet food and pet health combine
A modern strategy emerges from Boehringer following actions in vaccines and diagnostics
K-State aims to start global discussion on developing animal health's employees of the future
Products
Spanish start-up VLPbio in talks to license livestock immunotherapies
Valladolid-based VLPbio is in the process of establishing development partners for its pipeline of immunotherapeutic vaccines.
Latest From Product
US veterinary compounding companies to merge following acquisition
US veterinary drug compounding firms Wedgewood Pharmacy and Diamondback Drugs have agreed to a merger.
Boehringer extends Nexgard indications with new approval
Boehringer Ingelheim Animal Health's NexGard antiparasitic chewable tablet for dogs has gained a supplemental approval from the US FDA for the prevention of a bacterial infection.
Smart Flow cloud technology joins IDEXX
IDEXX Laboratories has expanded its veterinary cloud portfolio with the addition of a new clinical workflow system.
European Investment Bank supports French animal nutrition firm
The Roullier Group has received a €50 million ($59 million) loan from the European Investment Bank (EIB) to support innovation in animal and plant nutrition.
INVE Thailand receives authorization for export to Ecuador
INVE Aquaculture's Thailand business has become the first company in Asia to be given a certificate for direct import of its products into Ecuador.
Novus gains EU approval for poultry eubiotic
US firm Novus International has received approval for its Avimatrix poultry feed additive in Europe.
Data Pharm
Zoetis and Ceva build on vaccine intellectual property
Zoetis, Ceva Santé Animale and Bioveta have all made recent patent applications in the area of vaccine technology.
Sectors
Boehringer aims to help Latin America realize its potential through innovation
Fabio Paganini, the head of Boehringer Ingelheim's Latin America division, joined the firm just after its integration with Merial. At the recent Animal Health Innovation LatAm conference in São Paulo, Animal Pharm editor Joseph Harvey spoke to him about the firm's regional growth plans.
Latest From Sector
European Investment Bank supports French animal nutrition firm
The Roullier Group has received a €50 million ($59 million) loan from the European Investment Bank (EIB) to support innovation in animal and plant nutrition.
Animal Pharm seeks freelance special reports writers
Animal Pharm is looking for new authors for its animal health industry reports team.
Boehringer, Jurox secure supplemental FDA approvals
Boehringer Ingelheim Vetmedica has gained a supplemental US approval for Cystorelin (gonadorelin), which is used in reproductive synchrony programs for cattle.
Elanco adds ex-Zoetis director as head of companion animal R&D
Patrick Meeus has become Elanco's new senior director of global companion animal product development.
Animal health focus allows TyraTech to think big with its revenues, pipeline
Last year, TyraTech did the opposite of many companies and offloaded its human health business. Now with a focus on animal health, the Morrisville, North Carolina-based firm can pursue a more disciplined growth strategy. Animal Pharm editor Joseph Harvey spoke to the company's chief executive Bruno Jactel.
CannPal in Eurofins collaboration to expand cannabis therapeutic into cats
Australian firm CannPal Therapeutics has signed a research agreement with Eurofins Animal Health to develop a cannabis-derived pain therapeutic for cats.
Latest From Policy & Regulation
Meat industry, consumers raise red flags over FDA regulation of lab-grown meats
The US meat industry and consumer groups are raising red flags over the potential for the FDA to regulate lab-grown meat, poultry and seafood products.
EFSA establishes ASF data collection project
The European Food Safety Authority (EFSA) is funding a new initiative to improve the fight against African swine fever (ASF).
Agolin gets certification for first methane-reducing feed additive
The Carbon Trust has certified a feed additive from Swiss firm Agolin as the first of its kind to help reduce methane emissions in cows.
Best practices on-farm may be next frontier in battling Salmonella in chicken
Although food companies have been successful in bringing down Salmonella in chicken products, the next focus could be best practices on the farm.
Animal Pharm seeks freelance special reports writers
Animal Pharm is looking for new authors for its animal health industry reports team.
Associations watchfully optimistic after government Brexit plan
The UK animal health industry body has given the country's government a "cautious welcome" for its Brexit blueprint.
Policy & Regulation
AnimalhealthEurope: Legislation is a positive step but more could have been done on innovation
AnimalhealthEurope has given a broadly positive response to new legislation that should ensure greater access to animal medicines and cut industry red tape.
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.